HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study

Sequence and Haplotype Analysis Supports HLA-C as the Psoriasis Susceptibility 1 Gene

Rajan P. Nair, Philip E. Stuart, Ioana Nistor et al. · The American Journal of Human Genetics · 2006 · 602 citations · Full text

Life Sciences, Genetics, Immunology +14

The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis

Roberto Lande, Elisabetta Botti, Camilla Jandus et al. · Nature Communications · 2014 · 534 citations · Full text

Life Sciences, Dermatology, Immunology +14

Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

Robert Gniadecki, Knud Kragballe, T.N. Dam et al. · British Journal of Dermatology · 2011 · 250 citations

Medicine, Dermatology, Pharmacotherapy +12

HLA-Cw6-Positive and HLA-Cw6-Negative Patients with Psoriasis Vulgaris have Distinct Clinical Features

Jóhann E. Guðjónsson, Helgi Valdimarsson, Ari Kárason et al. · Journal of Investigative Dermatology · 2002 · 240 citations · Full text

Life Sciences, Dermatology, Immunology +12

Prevalence of symptoms experienced by patients with different clinical types of psoriasis

Francesca Sampogna, Paolo Gisondi, C.F. Melchi et al. · British Journal of Dermatology · 2004 · 200 citations

Medicine, Clinical Sciences, Dermatology +14